Healthcare provider profile · identity verified

Daniel L Zerbe, MD

Family Practice · PERRY, NY · NPI 1033101720

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	556	173
Atorvastatin Calcium	Atorvastatin Calcium	453	143
Losartan Potassium	Losartan Potassium	374	114
Rosuvastatin Calcium	Rosuvastatin Calcium	367	128
Levothyroxine Sodium	Levothyroxine Sodium	356	101
Omeprazole	Omeprazole	356	117
Metoprolol Succinate	Metoprolol Succinate	319	93
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	198	58
Pravastatin Sodium	Pravastatin Sodium	186	61
Metformin Hcl Er	Metformin Hcl	185	62
Hydrochlorothiazide	Hydrochlorothiazide	175	64
Eliquis	Apixaban	158	39
Gabapentin	Gabapentin	156	52
Lisinopril	Lisinopril	136	55
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	130	43
Pantoprazole Sodium	Pantoprazole Sodium	124	42
Jardiance	Empagliflozin	122	31
Metformin Hcl	Metformin Hcl	116	31
Metoprolol Tartrate	Metoprolol Tartrate	116	33
Spironolactone	Spironolactone	106	34
Famotidine	Famotidine	101	36
Fluticasone Propionate	Fluticasone Propionate	100	37
Tamsulosin Hcl	Tamsulosin Hcl	100	30
Allopurinol	Allopurinol	97	35
Ozempic	Semaglutide	95	25
Albuterol Sulfate Hfa	Albuterol Sulfate	91	37
Glimepiride	Glimepiride	91	32
Trazodone Hcl	Trazodone Hcl	90	35
Simvastatin	Simvastatin	89	32
Escitalopram Oxalate	Escitalopram Oxalate	85	25
Potassium Chloride	Potassium Chloride	82	27
Januvia	Sitagliptin Phosphate	80	19
Paroxetine Hcl	Paroxetine Hcl	80	17
Sertraline Hcl	Sertraline Hcl	74	27
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	71	29
Meloxicam	Meloxicam	68	20
Zolpidem Tartrate	Zolpidem Tartrate	67	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	66	18
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	66	33
Lovastatin	Lovastatin	65	21
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	64	29
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	64	19
Furosemide	Furosemide	63	25
Arexvy	Rsvpref3 Antigen/As01e/Pf	62	62
Alendronate Sodium	Alendronate Sodium	61	21
Duloxetine Hcl	Duloxetine Hcl	61	21
Clopidogrel	Clopidogrel Bisulfate	58	23
Carvedilol	Carvedilol	57	18
Finasteride	Finasteride	56	17
Shingrix	Varicella-Zoster Ge/As01b/Pf	55	47
Lorazepam	Lorazepam	52	22
Prednisone	Prednisone	50	29
Tramadol Hcl	Tramadol Hcl	50	22
Buspirone Hcl	Buspirone Hcl	46	15
Donepezil Hcl	Donepezil Hcl	44	14
Xarelto	Rivaroxaban	44	11
Montelukast Sodium	Montelukast Sodium	40	13
Trulicity	Dulaglutide	40	suppressed
Alprazolam	Alprazolam	39	14
Atenolol	Atenolol	39	14
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	39	suppressed
Warfarin Sodium	Warfarin Sodium	39	14
Bupropion Hcl Sr	Bupropion Hcl	38	12
Spironolactone-Hctz	Spironolact/Hydrochlorothiazid	37	12
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	36	suppressed
Citalopram Hbr	Citalopram Hydrobromide	36	suppressed
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	35	35
Breo Ellipta	Fluticasone/Vilanterol	35	suppressed
Celecoxib	Celecoxib	35	14
Amitriptyline Hcl	Amitriptyline Hcl	34	suppressed
Diclofenac Sodium	Diclofenac Sodium	33	18
Ibuprofen	Ibuprofen	33	suppressed
Bupropion Xl	Bupropion Hcl	31	11
Clonazepam	Clonazepam	31	suppressed
Ezetimibe	Ezetimibe	31	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	31	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	31	12
Hydralazine Hcl	Hydralazine Hcl	29	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	28	26
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	27	suppressed
Bumetanide	Bumetanide	27	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	27	suppressed
Farxiga	Dapagliflozin Propanediol	26	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	26	suppressed
Benazepril Hcl	Benazepril Hcl	25	suppressed
Symbicort	Budesonide/Formoterol Fumarate	25	suppressed
Azithromycin	Azithromycin	24	22
Lansoprazole	Lansoprazole	24	suppressed
Memantine Hcl	Memantine Hcl	24	suppressed
Torsemide	Torsemide	24	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	23	suppressed
Cephalexin	Cephalexin	22	19
Mirtazapine	Mirtazapine	22	11
Naproxen	Naproxen	22	suppressed
Ammonium Lactate	Ammonium Lactate	21	suppressed
Amoxicillin	Amoxicillin	21	14
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	21	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	21	suppressed
Propranolol Hcl Er	Propranolol Hcl	21	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	21	suppressed
Fenofibrate	Fenofibrate,micronized	20	suppressed
Ropinirole Hcl	Ropinirole Hcl	20	suppressed
Topiramate	Topiramate	20	suppressed
Divalproex Sodium	Divalproex Sodium	19	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	19	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	19	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	18	suppressed
Arnuity Ellipta	Fluticasone Furoate	17	suppressed
Colchicine	Colchicine	17	suppressed
Digoxin	Digoxin	17	suppressed
Nitroglycerin	Nitroglycerin	17	11
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	16	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	16	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	16	14
Meclizine Hcl	Meclizine Hcl	16	suppressed
Memantine Hcl Er	Memantine Hcl	16	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	16	suppressed
Valsartan	Valsartan	16	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	15	suppressed
Clobetasol Propionate	Clobetasol Propionate	15	suppressed
Hydrocortisone	Hydrocortisone	15	suppressed
Pregabalin	Pregabalin	15	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	15	13
Sumatriptan Succinate	Sumatriptan Succinate	15	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	15	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	15	suppressed
Fluconazole	Fluconazole	14	suppressed
Repaglinide	Repaglinide	14	suppressed
Risperidone	Risperidone	14	suppressed
Chlorthalidone	Chlorthalidone	13	suppressed
Diazepam	Diazepam	13	suppressed
Invokana	Canagliflozin	13	suppressed
Irbesartan	Irbesartan	13	suppressed
Low-Ogestrel	Norgestrel-Ethinyl Estradiol	13	suppressed
Methocarbamol	Methocarbamol	13	suppressed
Testosterone	Testosterone	13	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	13	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	12	suppressed
Carbamazepine	Carbamazepine	12	suppressed
Ibandronate Sodium	Ibandronate Sodium	12	suppressed
Levofloxacin	Levofloxacin	12	12
Methimazole	Methimazole	12	suppressed
Mupirocin	Mupirocin	12	suppressed
Nifedipine Er	Nifedipine	12	suppressed
Novolog Flexpen	Insulin Aspart	12	suppressed
Ofloxacin	Ofloxacin	12	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	12	suppressed
Tresiba Flextouch U-100	Insulin Degludec	12	suppressed
Ziprasidone Hcl	Ziprasidone Hcl	12	suppressed
Elmiron	Pentosan Polysulfate Sodium	11	suppressed
Ipratropium Bromide	Ipratropium Bromide	11	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	11	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	11	suppressed
Synthroid	Levothyroxine Sodium	11	suppressed
Temazepam	Temazepam	11	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error